CDC’s efforts with forecasting began in 2013 with the “Predict the Influenza Season Challenge”, a competition that encouraged outside academic and private industry researchers to forecast the timing, peak, and intensity of the flu season.
Changes were made in response to data becoming more difficult to interpret because of the ongoing COVID-19 pandemic.
Source: Centers for Disease Control and Prevention (CDC)
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
